Tert-butyl 4-[[1-[2-[4-[(3S)-3-(4-chlorophenyl)-3-[[4-[(2-methylpropan-2-yl)oxycarbonylamino]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]propyl]piperazin-1-yl]-2-oxoethyl]piperidin-4-yl]methyl]piperazine-1-carboxylate
C47H70ClN11O6 — CID 176761025
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[[1-[2-[4-[(3S)-3-(4-chlorophenyl)-3-[[4-[(2-methylpropan-2-yl)oxycarbonylamino]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]propyl]piperazin-1-yl]-2-oxoethyl]piperidin-4-yl]methyl]piperazine-1-carboxylate
Tert-butyl 4-[[1-[2-[4-[(3S)-3-(4-chlorophenyl)-3-[[4-[(2-methylpropan-2-yl)oxycarbonylamino]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]propyl]piperazin-1-yl]-2-oxoethyl]piperidin-4-yl]methyl]piperazine-1-carboxylate (PubChem CID 176761025) has the molecular formula C47H70ClN11O6 and a molecular weight of 920.60 g/mol. Its IUPAC name is tert-butyl 4-[[1-[2-[4-[(3S)-3-(4-chlorophenyl)-3-[[4-[(2-methylpropan-2-yl)oxycarbonylamino]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]propyl]piperazin-1-yl]-2-oxoethyl]piperidin-4-yl]methyl]piperazine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[[1-[2-[4-[(3S)-3-(4-chlorophenyl)-3-[[4-[(2-methylpropan-2-yl)oxycarbonylamino]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]propyl]piperazin-1-yl]-2-oxoethyl]piperidin-4-yl]methyl]piperazine-1-carboxylate |
|---|---|
| PubChem CID | 176761025 |
| Molecular Formula | C47H70ClN11O6 |
| Molecular Weight | 920.60 g/mol |
| Exact Mass | 919.52 |
| IUPAC Name | tert-butyl 4-[[1-[2-[4-[(3S)-3-(4-chlorophenyl)-3-[[4-[(2-methylpropan-2-yl)oxycarbonylamino]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]propyl]piperazin-1-yl]-2-oxoethyl]piperidin-4-yl]methyl]piperazine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)NC1(C(=O)N[C@@H](CCN2CCN(C(=O)CN3CCC(CN4CCN(C(=O)OC(C)(C)C)CC4)CC3)CC2)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1 |
| InChI | InChI=1S/C47H70ClN11O6/c1-45(2,3)64-43(62)53-47(15-21-58(22-16-47)41-37-11-17-49-40(37)50-33-51-41)42(61)52-38(35-7-9-36(48)10-8-35)14-20-54-23-27-57(28-24-54)39(60)32-55-18-12-34(13-19-55)31-56-25-29-59(30-26-56)44(63)65-46(4,5)6/h7-11,17,33-34,38H,12-16,18-32H2,1-6H3,(H,52,61)(H,53,62)(H,49,50,51)/t38-/m0/s1 |
| InChIKey | DVNRTAJDSBILNH-LHEWISCISA-N |
| XLogP | 5.13 |
| TPSA | 171.81 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 65 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 920.60 |
| LogP ≤ 5 | 5.13 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176761025 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.